Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.30

€3.30

1.850%
0.06
1.850%
-

-

 
26.04.24 / Stuttgart Stock Exchange WKN: A2AGVE / Name: MaxCyte Inc / Stock / Biotechnology & Medical Research / Micro Cap /
Your prediction

MaxCyte Inc Stock

There is an upward development for MaxCyte Inc compared to yesterday, with an increase of €0.060 (1.850%).
Our community identified positive and negative aspects for MaxCyte Inc stock for the coming years. 1 users see the criterium "Management" as a plus for the MaxCyte Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of MaxCyte Inc in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of MaxCyte Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
MaxCyte Inc 1.850% - - - - - -
Vaxart Inc. 1.810% -14.614% -48.896% -16.667% 18.988% -91.190% -
Jaguar Health Inc. 11.340% 13.936% 105.644% 114.322% 10.993% -99.945% -
aTyr Pharma Inc 0.690% -2.027% -20.765% -17.614% 12.403% -55.793% -81.604%